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Summary
Different classes of endosomes exhibit a characteris-
tic intracellular steady-state distribution governed by
interactions with the cytoskeleton. We found a
kinesin-3, KIF16B, that transports early endosomes to
the plus end of microtubules in a process regulated
by the small GTPase Rab5 and its effector, the phos-
phatidylinositol-3-OH kinase hVPS34. In vivo, KIF16B
overexpression relocated early endosomes to the cell
periphery and inhibited transport to the degradative
pathway. Conversely, expression of dominant-nega-
tive mutants or ablation of KIF16B by RNAi caused
the clustering of early endosomes to the perinuclear
region, delayed receptor recycling to the plasma
membrane, and accelerated degradation. These re-
sults suggest that KIF16B, by regulating the plus end
motility of early endosomes, modulates the intracellu-
lar localization of early endosomes and the balance
between receptor recycling and degradation. We pro-
pose that this mechanism could have important impli-
cations for signaling.
Introduction
The endocytic system is composed of a series of bio-
chemically and morphologically distinct organelles that
carry out specialized tasks in the uptake, recycling, and
catabolism of growth factors and nutrients, serving a
plethora of key biological functions (Mellman, 1996).
These functions require the interaction of endocytic
organelles with the actin and tubulin cytoskeleton.
Actin- and microtubule-dependent motors generate the
forces required to drive vesicle formation and delivery
to their target compartment (Howard et al., 1989). For
example, the unconventional myosin VI motor propels
clathrin-coated vesicles through the cortical actin mesh*Correspondence: zerial@mpi-cbg.de
4These authors contributed equally to this work.underneath the plasma membrane toward early endo-
somes (Aschenbrenner et al., 2004). Motor proteins
also serve several other important tasks, such as cargo
sorting through membrane tubulation and fission, en-
dosome inheritance, and positioning (Goldstein, 2001;
Goodson et al., 1997; Hirokawa et al., 1998). Endo-
somes have a characteristic intracellular distribution
and exhibit both short- and long-range movements
with a wide range of velocities (Gasman et al., 2003;
Nielsen et al., 1999; Valetti et al., 1999). Whereas early
endosomes are dispersed throughout the cytoplasm,
recycling endosomes, late endosomes, and lysosomes
are typically situated in close proximity to the nucleus.
This distribution pattern observed at steady state re-
sults from a dynamic interaction of endosomes with the
cytoskeleton. The minus end motor dynein-dynactin
complex is responsible for the perinuclear localization
of endosomes and lysosomes (Allan, 2000; Burkhardt
et al., 1997) but also for early-to-late endosome trans-
port (Aniento et al., 1993). Plus end, kinesin-dependent
motility facilitates exocytosis of cargo from recycling
endosomes to the cell surface (Lin et al., 2002). Micro-
tubule-dependent motility supports endocytic traffick-
ing between apical early and recycling endosomes as
well as transcytosis in polarized epithelial cells (Apo-
daca, 2001). However, a requirement for microtubule-
dependent transport has been demonstrated neither
for endocytosis nor for recycling from early endosomes
to the plasma membrane, which depends, rather, on
actin (Apodaca, 2001). Furthermore, it remains unclear
which microtubule motors besides dynein control the
intracellular distribution and motility of early endo-
somes and how their function is integrated with the
sorting and transport of cargo.
Increasing evidence points at a role of Rab-GTPases
in coordinating membrane tethering and fusion with cy-
toskeleton-dependent organelle motility (Echard et al.,
1998; Jordens et al., 2001; Zerial and McBride, 2001).
On early endosomes, the small GTPase Rab5 coordi-
nates the activity of several effector proteins that coop-
eratively regulate endocytic trafficking (Zerial and
McBride, 2001). A key effector of Rab5 is the phospha-
tidylinositol-3-OH kinase (PI3-K) hVPS34/p150 that, by
generating PI(3)P in proximity to Rab5, allows the re-
cruitment of Rab5 effectors bearing the PI(3)P binding
FYVE motif. The concerted activity of Rab5 and hVPS34
is also required for bidirectional, microtubule-based,
endosome motility in vitro (Nielsen et al., 1999), raising
the question of which molecular motor(s) may function
downstream.
The superfamily of kinesin proteins (KIF) drives a
great variety of microtubule-dependent motility events
(Goldstein, 2001; Goodson et al., 1997; Hirokawa et al.,
1998). Each kinesin contains a conserved “motor do-
main” as well as a variable tail, mediating cargo speci-
ficity. The Unc104/KIF1A kinesin, which transports
synaptic vesicle precursors, utilizes its pleckstrin ho-
mology (PH) “tail domain” to bind directly to PI(4,5)P2
lipids (Klopfenstein et al., 2002).
The finding that Rab5-dependent early endosome
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439coiled-coil structure of KIF16B with all human kinesin-3 PI(3)P, PI(3,4)P2, and PI(3,4,5)P3 with affinities (KD = 28
Figure 1. KIF16B, a Close Paralog to KIF1A, Exhibits Structural Properties of a Dimeric, Plus End-Directed Kinesin
(A) Conserved domains within HsKIF16B include the N-terminal kinesin motor domain (KISc), the forkhead domain (FHA), and the PX domain
at the C terminus.
(B) The kinesin KIF16B is most closely related to HsKIF1A.
(C) The putative neck linker region (blue), the neck (yellow), and part of the hinge region (green) of HsKIF16B were aligned against HsKIF1A
as well as HsKHC. The heptad repeats are very similar to KIF1A. Asterisks (*) mark residues that are well conserved in plus ended-directed
motors, and predicted β sheets as well as α helices are indicated above the alignment.
(D) COILS prediction of coiled-coil structures within HsKIF1A and KIF16B as well as KHC. Scores above 0.5 represent significant probability
that coiled-coil structures are present.motility depends on PI(3)P raises the possibility that
this lipid may recruit an adaptor of a motor or, in the
simplest case, a motor itself (Nielsen et al., 1999). To
date, two distinct conserved structural motifs, the FYVE
finger and the PhoX homology (PX) domain, are known
to bind PI(3)P (Lemmon, 2003). Here, we searched for
motor proteins displaying such motifs.
Results
Identification and Cloning of the Kinesin KIF16B
A genome sequence database search was devised to
identify candidate kinesins harboring either a FYVE or
PX motif. This search revealed a gene encoding a
putative motor protein with a C-terminal PX domain in
D. melanogaster (DmKLP98A) as well as a previously
unknown ortholog in Fugu T. rubripes (JGI32205). The
paucity of introns in the Fugu genome, together with
the high similarity of the Fugu kinesin to the human or-
tholog, enabled us to predict the equivalent open read-
ing frame in H. sapiens (KIF16B, accession number
BX647572). To our knowledge, next to KIF1A, KIF16B
represents the only other example of an evolutionary
conserved kinesin-like protein, bearing a putative lipid
binding domain across all genomes sequenced so far.
A cDNA encoding full-length hsKIF16B was cloned and
found, in comparison to the BX647572 cDNA, to con-
tain a single nucleotide polymorphism (SNP) at position
820 (G820A). KIF16B is a protein of 1318 amino acid
residues with a deduced molecular weight of 152 kDa
(Figure 1A). It is predicted to be a plus end motor pro-
tein on the basis of (1) the N-terminal localization of the
structurally conserved catalytic domain (amino acids
1–355) and (2) the presence of four conserved amino
acids C-terminally to the α-6 helix (Figure 1B) (Case et
al., 1997).
According to the recent nomenclature (Lawrence et
al., 2004), KIF16B is a member of the kinesin-3 family,
encompassing a total of eight members in the human
genome (Figure 1C). Its closest paralogue in H. sapiens
is KIF1A, sharing 59% sequence identity in the motor
domain. KIF16B displays two diagnostic properties of
the kinesin-3 family, a conserved insertion in loop 3
and a forkhead homology (FHA) domain in its stalk
(Vale, 2003). Kinesins of this family are thought to exist
either as monomers like hsKIF1A (accession number
CAA62346) or dimers such as DdKIF1A (accession
number X65873), depending on the presence of coiled-
coil motifs (Vale, 2003). Using the COILS algorithm (Lu-
pas et al., 1991), we compared the predicted content infamily members and deduced that KIF16B has a much
higher coiled-coil propensity in its stalk, analogous to
that of dimeric D. discoideum KIF1A and KHC (Pollock
et al., 1999) (Figure 1D).
Whereas many KIFs are primarily expressed in brain
(Miki et al., 2003), KIF16B is also present in various
other organs, e.g., kidney, liver, intestine, placenta, leu-
kocytes, heart, and skeletal muscle by Northern and
Western blot analysis (see Figure S1 in the Supple-
mental Data available with this article online), in agree-
ment with the broad expression pattern for this gene
(C20orf23) reported in the genome-wide expression da-
tabase GeneNote (Shmueli et al., 2003).
KIF16B Is a Plus End-Directed Motor
Recombinant KIF16B expressed and purified from a
baculovirus system was tested for the directionality of
movement using an in vitro assay based on polarity-
marked microtubules (Hyman, 1991). In this assay,
taxol-stabilized microtubules with bright fluorescent
plus ends move on a glass slide coated with the motor
protein. In line with our bioinformatics prediction, the
majority of microtubules (24 out of 28) were found to
glide toward their dimly labeled minus ends (Figure 2A).
Purified KIF16B mediated microtubule gliding with ve-
locities between 0.175 and 0.275 m/s (Figure 2B).
These values are in the same range of long-distance
movements of early endosomes in vivo, typically dis-
playing velocities of w0.3m/s (Gasman et al., 2003)
(Supplemental Data). The velocity depends both on the
intrinsic properties of the catalytic domain and the sta-
bility of the coiled coil in the neck (Vale, 2003). Although
the neck of KIF16B is similar to that of KIF1A (Figure
1C), it differs considerably in the coiled-coil propensity
of its stalk (Figure 1) and in its velocity (w1.20 m/s in
vitro [Okada et al., 1995] and 1.02 m/s in vivo [Zhou
et al., 2001] for KIF1A).
KIF16B Is Localized to PI(3)P-Containing Early
Endosomes In Vivo
A key feature of KIF16B is the PX domain at the C termi-
nus that could target the motor to early endosomes via
binding to PI(3)P. We measured the binding kinetics of
the PX domain of KIF16B fused to GST (GST-CtermPX)
by plasmon resonance using a sensor chip coated with
different PIs (Figure 2C). Whereas the PX domain of
KIF16B did not bind to PI(4,5)P2, unlike KIF1A and
Unc104 motors (Klopfenstein et al., 2002), it bound to
Cell
440Figure 2. KIF16B Is a Processive, Plus End-
Directed Motor and Binds PI(3)P through its
PX Motif
(A) Video microscopy was used to capture
movements of labeled microtubules over a
lawn of kinesin molecules on a glass slide.
Each microtubule carries a short stretch of
fluorescently labeled tubulin on its minus
end. The still images shown reveal move-
ment of microtubules in direction of their mi-
nus ends (*), driven by the plus end motility
of the kinesins.
(B) Velocity distribution of the microtubules
in (A). Each recorded motility event repre-
sents microtubules continuously moving for
at least three consecutive frames without
switching direction.
(C) GST-KIF16B-PX protein was injected into
plasmon resonance sensor chips loaded with
liposomes containing 2 mol% of each PI. An
average KD was obtained for each PI. No
binding (signal below baseline level, i.e., less
than 2 RU) was observable for GST protein
alone and GST-KIF16B-PX and PI(3,4)P2.nM, 40 nM, and 99 nM, respectively) comparable to
ithose reported for the FYVE domain of Hrs binding to
PI(3)P (KD of 38 ± 19 nM) (Gillooly et al., 2000). q
tWhereas FYVE fingers specifically interact with
PI(3)P, PX domains generally do not exhibit the same t
wselectivity (Lemmon, 2003). Since PI(3)P is localized to
endosomes, while both PI(3,4)P2 and PI(3,4,5)P3 are l
Ktypically found at the plasma membrane, we next deter-
mined the intracellular localization of KIF16B in vivo. An d
Eaffinity-purified rabbit antiserum raised against recom-
binant, truncated (headless) KIF16B protein (see Ex- d
2perimental Procedures) detected the endogenous pro-
tein by confocal immunofluorescence microscopy and
tWestern blot analysis (see below). In HeLa cells (Figure
3A), endogenous KIF16B almost completely over- d
ilapped with myc-tagged double FYVE serving as a
probe for PI(3)P on early endosomes (Gillooly et al., M
c2000). Given the background nuclear staining of the an-
tibody (persisting by labeling with the preimmune se- s
crum or upon ablation of KIF16B by RNAi, see Figure
6G), we verified that exogenous KIF16B also localized (
lto PI(3)P-positive early endosomes (Figure 3B). No evi-
dence for plasma membrane localization could be ob- m
ptained. Importantly, at low expression levels, the exoge-
nous KIF16B motor did not significantly alter the i
Pdistribution of early endosomes (see below).In view of the binding of the KIF16B PX motif to PI(3)P
n vitro, we next tested whether this phospholipid is re-
uired for targeting KIF16B fused to YFP (KIF16B-YFP)
o early endosomes (Gillooly et al., 2000). The genera-
ion of PI(3)P can be inhibited pharmacologically,
ith the fungal toxin Wortmannin or LY294002 (see be-
ow). Upon treatment with 100 nM Wortmannin, most
IF16B-YFP detached from endosomes, leading to a
iffuse cytosolic staining pattern (Figures 3C and 3D).
EA1, which localizes to the Rab5 domain of early en-
osomes PI(3)P dependently (Zerial and McBride,
001), served as a positive control.
On early endosomes, Rab5 recruits effectors bearing
he FYVE domain via a dual mechanisms, i.e., (1) by
irect binding and (2) through generation of PI(3)P via
nteraction with the PI3-K hVPS34/p150 (Zerial and
cBride, 2001). While we were unable to detect spe-
ific binding of KIF16B to Rab5 in vitro (data not
hown), expression of dominant-negative Rab5S34N
aused the release of KIF16B from endosomes in vivo
Figures 3E and 3F). This suggests that the membrane
ocalization of KIF16B most likely depends on Rab5-
ediated PI(3)P production. Altogether, the above ex-
eriments provide strong evidence that KIF16B is local-
zed to PI(3)P-positive early endosomes in a Rab5- and
I3-K-dependent manner in vivo.
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441Figure 3. The Kinesin KIF16B Requires the Presence of PI(3)P as well as Rab5 Activity to Localize to Endosomes
HeLa cells were transfected with the PI(3)P lipid probe 2xFYVE-myc as well as with KIF16B-YFP prior to immunofluorescence microscopy
with anti-myc and anti-Kif16B antisera. The confocal images show almost complete colocalization of endogenous (A) and ectopic (B) KIF16B
with the endosomal marker 2xFYVE. (C) To examine the interaction of KIF16B and PI(3)P in vivo, transfected cells expressing KIF16B-YFP
were incubated in the presence (D) or absence (C) of 100 nM Wortmannin for 20 min at 37°C and then processed for immunofluorescence
for EEA1. (E) HeLa cells were cotransfected with KIF16B-YFP (green) and Rab5-CFP (blue) or KIF16B-YFP and dominant-negative Rab5-
S34N-CFP (F). Overexpression of the Rab5 mutant results in release of KIF16B to the cytosol. Scale bars, 20 m.
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Ealong Microtubules In Vitro
Having established that the PX motif of KIF16B binds t
cPI(3)P in vitro and localizes to membranes bearing this
lipid in vivo, we next tested whether recombinant full- n
elength KIF16B can be recruited onto PI(3)P-containing
liposomes in a manner competent for transport. KIF16B b
3was incubated with fluorescent liposomes with or with-
out 2 mol% of PI(3)P. The suspension was applied to a
uchamber containing fluorescently labeled taxol-stabi-
lized microtubules immobilized on the glass surface r
s(Nielsen et al., 1999). True motility events, scored as
movement of liposomes along the fluorescently labeled a
rmicrotubule tracks, were differentiated from Brownian
motion of immobile, microtubule bound liposomes. r
sWhereas PI(3)P-free liposomes (Figures 4A and 4C)
were unable to bind to microtubules (green) and dif- i
sfused in the buffer in the presence of KIF16B, the
PI(3)P-containing liposomes (Figures 4B and 4D) were l
trecruited to and transported along microtubules, exhib-
iting continuous motion (displacement >3 m) and m
fvelocity similar to microtubule gliding (Figure 2). These
data provide further evidence that interaction of KIF16B (
qwith PI(3)P is sufficient to move liposomes in vitro.
m
fKIF16B-Mediated Transport of Early Endosomes
Depends on Rab5 and hVPS34 Activity s
tTo test the hypothesis that KIF16B may participate in
the Rab5- and PI(3)P-dependent early endosome motil- A
qity (Nielsen et al., 1999), we first confirmed the presence
of endogenous KIF16B on purified early endosomes. tFigure 4. KIF16B Confers Motility to PI(3)P-
Containing Liposomes In Vitro
The binding of KIF16B to and movement of
liposomes in an in vitro motility assay de-
pends on the presence of PI(3)P. Liposomes
were composed of phosphatidylcholine and
fluorescently labeled phosphatidylethanolam-
ine, as a negative control (left panel), or the
same mixture supplemented with 2 mol% of
PI(3)P (right panel). Shown are still images of
liposomes (red) and microtubules (green) in
the top panel and collapsed video stacks
displaying liposome movement in the bottom
panel. PI(3)P-containing liposomes show
motility along microtubules. Each collapsed
movie represents 60 frames in a time resolu-
tion of one frame per 2 s. Scale bar, 5 m.ndogenous KIF16B cofractionated with Rab5 and
EA1 (Figure 5A) on an early endosome-enriched frac-
ion (Nielsen et al., 1999). Overexpression of KIF16B in-
reased, whereas pretreatment of cells with Wortman-
in reduced, the amount of EEA1 and KIF16B on the
ndosomal fraction (Figure 5A), consistent with PI(3)P
eing required for their membrane recruitment (Figures
C and 3D).
The cofractionation with early endosomes prompted
s to explore the activity of KIF16B in an assay that
ecapitulates the bidirectional movement of early endo-
omes in a cell-free system (Nielsen et al., 1999). In this
ssay, early endosomes, purified from HeLa cells fluo-
escently labeled by internalization of rhodamine-transfer-
in, are combined with cytosol, energy regenerating
ystem, and buffered antifade mixture and perfused
nto a glass chamber coated by a uniform lawn of taxol-
tabilized microtubules. Moving endosomes are ana-
yzed by video microscopy. Since KIF16B moves
oward the plus end of microtubules (Figure 2), we
odified the experimental conditions to uncouple plus-
rom minus ended motility in the absence of cytosol
see Experimental Procedures). In this assay, the fre-
uency of motility events, velocities, and lengths of
ovements of endosomes approximated the values
rom the cytosol-dependent assay. The motile endo-
omes exhibited track lengths and velocities similar to
he PI(3)P-containing liposomes (Figures 5B and 5C).
ddition of recombinant KIF16B stimulated the fre-
uency of motility events (Figures 5E and 5F). Consis-
ent with previous data (Nielsen et al., 1999), endosome
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443Figure 5. KIF16B Cofractionates with Early Endosomes and Modulates Plus End Motility of Early Endosomes in a Rab-5-Dependent Manner
(A) Early endosome-enriched fractions were analyzed by immunoblotting with EEA1, Rab5, and KIF16B antibodies. Endosomes purified from
cells pretreated for 20 min with 100 nM Wortmannin (WM) show reduced amounts of EEA1 and KIF16B in comparison with endosomes from
control cells (DMSO). Cells overexpressing exogenous KIF16B (Exog.) show an increased amount of KIF16B, while KIF16B preimmune serum
shows no detectable signal on early endosomes.
(B) Rh-Transferin-labeled early endosomes move on microtubules in the presence of KIF16B. Shown are collapsed movie images from the in
vitro motility assay (see Experimental Procedures). An image of a collapsed movie stack displays moving endosomes as continuous lines.
(C) The velocity distribution of moving endosomes in (B) shows motility events ranging from 0.05 to 0.3 m/sec.
(D–F) The in vitro motility assay was carried out in the presence or absence (i.e., buffer or preimmune serum) of various reagents, and the
recorded events per unit time were quantified (data are represented as mean ± SD). Inhibition of motility is seen in the presence of RabGDI,
LY2344, truncated KIF16B protein, and antibodies against hVPS34 or KIF16B, while a stimulation of motility was observed upon addition of
recombinant KIF16B or Rab5-GDI complex. The effect of the function blocking anti-KIF16B antibodies could be rescued by excess KIF16B
protein (E). In the presence of exogenous KIF16B, early endosomes retained their responsiveness to the modulation of motility by Rab5 (F).
Scale bar, 5 m.
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444motility was Rab5 and PI(3)P dependent. First, extrac- a
ition of Rab proteins from the endosome membrane
with excess of RabGDI decreased, whereas addition of t
oRab5-GDI complex stimulated, the number of motility
events (Figures 5D and 5F). Second, inhibition of PI(3)- A
tkinase either by LY294002 or specific hVPS34 function-
blocking antibodies (Nielsen et al., 1999) inhibited the c
Tmotility of early endosomes (Figure 5D). Importantly,
endosome motility along microtubules was not only a
pstimulated by but also dependent on KIF16B activity.
Movement was strongly inhibited by addition of either l
iKIF16B-N, a KIF16B deletion mutant protein lacking
the catalytic domain, or affinity-purified anti-KIF16B an- c
ctibodies. The antibody inhibition was specific, as it
could be overcome by supplying recombinant KIF16B s
nprotein (Figure 5E). Furthermore, in the presence of ex-
ogenous KIF16B, the system maintained its sensitivity 4
Stoward Rab-GDI and Rab5-GDI complex (compare Fig-
ure 5F with Figure 5D). i
tThe finding that dominant-negative Rab5S34N dis-
places KIF16B from endosomes in vivo (Figure 4F), to- p
sgether with the dependence on Rab5 as well as hVPS34
activity for the motility in vitro, suggests that KIF16B is w
pa motor protein that fulfils the biochemical properties
previously established for the plus ended motility of t
eearly endosomes in vitro (Nielsen et al., 1999).
m
6KIF16B Regulates the Steady-State Distribution
tof Early Endosomes
tHaving established a role of KIF16B in early endosome
amotility in vitro, we explored its function with respect
sto endosome distribution and transport in vivo. To this
gend, we compared the effects of full-length KIF16B-
eYFP overexpression in HeLa cells with silencing of the
eendogenous motor by RNA interference and the ex-
pression of two dominant-negative KIF16B mutants.
The first one lacked the catalytic domain, retaining the K
stalk and PX domain unaltered (KIF16B-N-YFP). Anal- T
ogous truncation mutants have been reported to in- T
terfere with cargo localization (Noda et al., 2001). The m
second (KIF16B-S109A-YFP) had a point mutation in t
the nucleotide binding motif, thus impairing motor ac- t
tivity as shown for kinesin (Nakata and Hirokawa, 1995). c
Opposite effects on the intracellular distribution of p
early endosomes were observed in these gain- and d
loss-of-function studies. While early endosomes strik- f
ingly relocalized to the cell periphery upon overexpres- r
sion of KIF16B-YFP (Figure 6A), either of the two t
KIF16B mutants (Figures 6B and 6C) caused their clus- m
tering in the perinuclear region. A similar effect was d
produced by reducing KIF16B protein expression by p
w90% using esiRNA (see Figure S1) (Figures 6E and E
6F). Importantly, none of the various constructs re- a
sulted in any gross morphological alteration of the (
microtubule network, e.g., microtubule bundling or de- p
polymerization (data not shown). These results suggest i
that, in regulating plus end motility, KIF16B governs the E
spatial distribution of early endosomes in vivo. t
b
aAblation of KIF16B Expression Perturbs the
Recycling Function of Early Endosomes S
cWe next explored the role of KIF16B in the uptake of
cargo into early endosomes, recycling to the surface, Und delivery to late endocytic compartments. We first
nvestigated whether the activity of KIF16B affects the
ransferrin (Tfn) cycle. Whereas overexpression of vari-
us KIF16B constructs did not impair uptake of
lexa568-labeled Tfn (Figure 6F, data not shown), abla-
ion of KIF16B by RNAi accelerated its accumulation
ompared with mock-treated cells (Figures 6G and 6H).
o quantify this effect, serum-starved HeLa cells were
llowed to internalize biotinylated Tfn for various
eriods of time, washed, and lysed, and the intracellu-
ar fraction of Tfn was determined. Silencing of KIF16B
ndeed resulted in a faster rate of Tfn accumulation
ompared with control cells (Figure 6I). Since this effect
ould be due to a diminished recycling from early endo-
omes to the plasma membrane, we measured the ki-
etics of Tfn recycling, taking care not to chill cells to
°C to avoid depolymerization of microtubules (Jin and
nider, 1993). Firstly, biotinylated Tfn was internalized
nto cells for 2 min. Under these conditions, endocy-
osed Tfn primarily reaches early endosomes but not
erinuclear recycling endosomes. After a brief washing
tep to remove surface bound Tfn, cells were chased
ith 100-fold excess of unlabeled Tfn for different
eriods of time, and the amount of biotinylated Tfn re-
ained in the cells was quantified. Silencing of KIF16B
xpression delayed Tfn recycling back to the plasma
embrane in comparison to mock-treated cells (Figure
H). Secondly, when the tracer was internalized for 1 hr
o saturate perinuclear recycling endosomes, no inhibi-
ion of Tfn recycling was observed (compare Figures 6J
nd 6K), arguing that transport from recycling endo-
omes to the surface was not affected. These data sug-
est that, besides determining the distribution of early
ndosomes (Figure 5), KIF16B is also required for their
fficient recycling of cargo to the cell surface.
IF16B Overexpression or Ablation Alters EGF
rafficking In Vivo
ransport of cargo from early to late endosomes is
icrotubule dependent and requires the minus end mo-
or dynein (Aniento et al., 1993). To investigate whether
he accumulation of early endosomes underneath the
ell cortex induced by overexpression of KIF16B im-
airs the sorting of cargo from early endosomes to the
egradative pathway, we measured epidermal growth
actor (EGF)-induced receptor internalization and deg-
adation. HeLa cells expressing either wild-type or mu-
ant KIF16B-S109A were stimulated with EGF for 30
in or 6 hr in the presence of cyclohexamide to prevent
e novo synthesis of EGFR. Cells were subsequently
rocessed for immunofluorescence staining with anti-
GFR antibodies and imaged by confocal microscopy,
nd signal intensities were quantified as described
Bache et al., 2003). In control cells, consistent with
revious reports (Sorkin et al., 1991), EGFR was found
n early and late endosomes during the first 30 min of
GF stimulation followed by almost complete degrada-
ion after 6 hr (Figure 7A). Overexpression of KIF16B
ut not KIF16B-S109A prevented EGF (data not shown)
nd EGFR from entering the degradative pathway.
trikingly, EGFR persisted in early endosomes at the
ell cortex over 6 hr after internalization (Figure 7A).
nder these conditions, the perinuclear localization of
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445Figure 6. KIF16B Regulates the Steady-State Distribution of Early Endosomes and Is Required for Efficient Transferrin Recycling
HeLa cells were transfected with KIF16B-YFP ([A], green), KIF16B-N-YFP ([B] and [F], green), or KIF16B-S109A-YFP (C). After transfection
(24 hr), cells were immunostained with antibodies against EEA1 ([A]–[C], red) or pulsed with transferrin-Alexa568 for 30 min at 37°C followed
by a 10 min chase to remove surface bound transferrin ([F], red). While EEA1 and transferrin-labeled endosomes translocate to the cell
periphery upon overexpression of wild-type KIF16B (A), they cluster in the perinuclear region upon expression of the dominant negative
constructs (B, C, and F). Also, knockdown of KIF16B results in centripetal translocation of early endosomes (D and E), while the morphology
of Rab11-CFP-labeled recycling endosomes remains unaltered (K). (G, H, and I) Tfn uptake and recycling experiments. RNAi-treated HeLa
cells were allowed to take up Alexa568-labeled Tfn for the indicated times and processed for fluorescence microscopy. Ablation of endoge-
nous KIF16B (G) leads to an intracellular accumulation of Tfn (40 min) in comparison with mock-treated (H) cells. (I) Cells treated with
unspecific (triangles) or KIF16B-specific esiRNA (squares) were allowed to take up biotinylated Tfn for the indicated times, washed, and
lysed, and internalized Tfn was quantified. To examine if KIF16B function affects Tfn recycling from early endosomes (J) or from recycling
endosomes (K), RNAi-treated cells were subjected to pulse chase experiments with biotinylated Tfn. Cells were loaded with Tfn for 2 min (J)
or 1 hr (K), washed, and incubated at 37°C in medium containing 100-fold excess unlabeled Tfn. Internalized Tfn was quantified (see Experi-
mental Procedures) and expressed as a percentage of total. Data from Tfn uptake and recycling assays are represented as mean ± SD. Scale
bar, 20 m.
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(A) HeLa cells were transfected with full-length KIF16B-YFP or dominant-negative KIF16-S109A-YFP constructs. Posttransfection (24 hr), the
cells were induced with EGF (0.1 M) in the presence of cycloheximide (10 g/ml) for the indicated times and immunostained with antibodies
to EGFR (Aa–Ad) or LAMP1 (Ae). Merge shows the superimposed confocal images of the kinesin (green) and EGFR or LAMP1 (red). Mock
transfected cells (data not shown) as well as cells expressing KIF16-S109A-YFP almost completely degrade EGFR over the course of 6 hr
(Aa and Ab). In contrast, overexpression of wild-type KIF16B-YFP inhibits EGFR degradation (Ac and Ad), while it does not affect localization
of late endosomes stained with LAMP1 antibodies (Ae). The asterisks (*) mark the cell that overexpresses KIF16B.
(B) Quantification of EGFR signal (mean ± SEM) present in (A).
(C) Cells overexpressing KIF16B show significantly less degradation of EGFR. Cells were induced for the indicated times with EGF and
immunoblotted for EGFR, and the blots were quantified. The amount of EGFR degraded is expressed as a percentage of total EGFR present
before induction. The mean and SD from three independent experiments are shown.
(D) HeLa cells were induced for the indicated times with EGF and immunoblotted for EGFR and α-tubulin as a reference. Cells pretreated
with RNAi specific for KIF16B show slightly accelerated degradation of EGFR as evident 2 hr after induction. Scale bar, 20 m.late endosomes, as visualized by LAMP1 staining, was a
runaffected (Figure 7A). That EGFR accumulated in early
endosomes was indicated by the colocalization with p
qRab5, Tfn, EEA1, and PI(3)P but not the late endosome
marker LAMP1 or lysotracker DND-99 (Figures 3 and 7
and Figure S1). All degradation kinetics of EGFR deter- D
mined morphologically could also be confirmed bio-
chemically (Figures 7B and 7C). Ablation of KIF16B by T
RNAi produced the opposite phenotype, i.e., acceler-ted the degradation of EGFR (Figure 7D). From these
esults, we conclude that KIF16B regulates the trans-
ort of cargo from early to late endosomes and, conse-
uently, its degradation.
iscussion
he balance between plus and minus end-directed
microtubule motors determines the intracellular local-
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447ization of early endosomes, recycling endosomes, late
endosomes, and lysosomes. Here we report that
KIF16B regulates the plus end motility of early endo-
somes and their intracellular distribution. With the find-
ings that alterations of KIF16B function also affected
the Tfn cycle and transport from early to late endo-
somes, we provide evidence for a role of this motor in
regulating endosome location and the balance between
receptor recycling and degradation.
KIF16B Is a Plus End Motor of Early Endosomes
KIF16B fulfils the functional properties expected for an
early endosome kinesin. Motility studies indicated that
the dynamic properties of recombinant KIF16B in vitro
match some of the parameters measured for early en-
dosome movement in vivo. First, KIF16B can transport
membrane cargo over distances exceeding 3 m, thus
sustaining the long-range movement displayed by early
endosomes in vivo (Gasman et al., 2003). The short-
distance movements of early endosomes are due to the
association with actin filaments promoted by the small
GTPase RhoD (Gasman et al., 2003). Second, in HeLa
cells, w20% of Rab5-positive early endosomes move
with velocities lower than 0.4 m/sec, w50% 0.4–0.8
m/sec, and w30% higher than 0.8 m/s (Gasman et
al., 2003). The velocities measured in vitro for KIF16B
thus approximated the lower velocities of Rab5-labeled
endosomes in vivo (velocity distribution around 0.35
m/sec). Conventional KHC, which propels several
types of organelles (Goldstein, 2001; Goodson et al.,
1997; Hirokawa et al., 1998), displays w2- to 3-fold
higher velocities in vitro (Vale et al., 1985; von Massow
et al., 1989). Early endosomes may well rely on multiple
kinesins for propulsion, also depending on the cell
type. For example, KIFC2, which was implicated in
early endosomal motility, is likely restricted to neurons
(Yang et al., 2001). However, besides its ubiquitous ex-
pression, a unique feature of KIF16B among KIFs is that
it contains an important hallmark of early endosome
targeting, the PX domain. This domain allows KIF16B
to bind and move PI(3)P-containing liposomes and lo-
calize to early endosomes. Importantly, in vivo studies
confirmed the idea that KIF16B is required for the
proper intracellular distribution of early endosomes.
Next to the well-characterized Unc104/KIF1A,
KIF16B represents the only other kinesin motor with the
ability to directly interact with lipids. Since PX domains
frequently require dimerization to bind PI(3)P (Lemmon,
2003), it is conceivable that the high coiled-coil poten-
tial of its stalk is sufficient for KIF16B to dimerize. This
raises the question of whether the regulation of KIF16B
motility follows a cooperative model, as proposed for
Unc104 and Kif1A, for which clustering in lipid rafts
leads to high density of motor monomers, thus facilita-
ting dimerization and processive transport (Klopfenstein
et al., 2002). Given its high coiled-coil propensity,
KIF16B is in all likelihood a dimer like D. discoideum
Unc104 and does not follow this cooperative transition
upon recruitment to early endosomes.
Coupling of Membrane Fusion with Early Endosome
Motility via Rab5 and PI(3)P
In displaying Rab5- and PI(3)P-containing cargo selec-
tivity, a remarkable property of KIF16B is that it is sub-jected to the same regulatory principles governing the
membrane tethering and fusion machinery (Zerial and
McBride, 2001). Even though Rab5 and KIF16B do not
appear to interact directly, Rab5 can modulate the gen-
eration of PI(3)P in its vicinity via its direct interaction
with hVPS34/p150 (Christoforidis et al., 1999) (Shin,
personal communication), thus allowing for the binding
of the PX domain of KIF16B to the endosomal mem-
brane. This mechanism reiterates the role of Rab5 in
creating a specialized membrane domain in which the
activities of different effectors can be kinetically con-
trolled by the GTPase cycle and coordinated through
spatial segregation within restricted subcompartments
of the early endosome (Zerial and McBride, 2001).
Our study strengthens the emerging paradigm that
Rab GTPases, besides functioning in membrane fusion,
also orchestrate organelle movement. Rab11 and
Rab27 regulate the membrane recruitment of myosin
motors onto recycling endosomes and melanosomes
(Hales et al., 2002; Wu et al., 2002). Rabkinesin-6 was
proposed to be an effector of Rab6 regulating the
movement of Golgi membranes (Echard et al., 1998),
although recent studies argue, rather, for a function in
cytokinesis (Hill et al., 2000). Finally, the Rab7 effector
RILP was shown to indirectly regulate the recruitment
of the dynein-dynactin complex to late endosomes
(Jordens et al., 2001).
In the case of early endosomes, Rab5 and PI(3)P ap-
pear to regulate both the plus- and minus end motility
of early endosomes (Nielsen et al., 1999), raising the
question of how bidirectional movement is regulated.
For example, the bidirectional movement of melano-
somes is coordinated by dynactin, which binds both
dynein and the plus end motor kinesin II (KIF3) (Deacon
et al., 2003; Valetti et al., 1999). In the absence of cyto-
sol, isolated early endosomes exhibit only plus end mo-
tility in vitro, suggesting that minus end-directed mo-
tors must either be lost or inactivated during the
fractionation procedure. However, rather than the direc-
tion of movement being determined by stochastic mo-
tor recruitment or competition between motors of op-
posite polarity, precise regulatory mechanisms are
required to switch them on and off (Reilein et al., 2001).
A possible regulatory mechanism for the activity of
KIF16B could be phosphorylation, given the presence
of a phosphothreonine/serine binding FHA domain (Du-
rocher and Jackson, 2002).
The Role of KIF16B in Endosome Motility, Cargo
Transport, and Signal Transduction
Our data suggest that microtubule-dependent motility
plays a role in the regulation of endocytic transport at
earlier stages than previously assumed. Microtubule-
dependent motility facilitates trafficking from early to
late endosomes but is not required for the recycling of
ligand/receptor complexes from early endosomes to
the surface (Apodaca, 2001), a process that rather de-
pends on actin (Apodaca, 2001). Our data suggest that
plus end motility along microtubules may facilitate the
targeting of recycling carriers from early endosomes to
the plasma membrane. This may be a prerequisite to
switch from microtubule- to actin-based transport to al-
low efficient cargo exocytosis. Proximity of early endo-
somes to the cell cortex may also favor fast over slow
Cell
448grecycling via perinuclear recycling endosomes (Max-
nfield and McGraw, 2004), as also observed for Rabeno-
tsyn-5 (de Renzis et al., 2002). Interestingly, inhibitors of
c
PI(3)-kinase cause a significant retention of transferrin
in early endosomes (van Dam et al., 2002). Such inhibi- C
tion could be explained, at least in part, by the release a
Hof KIF16B from the early endosome membrane (Figure 3).
DTransport along the degradative pathway, either me-
tdiated by endosomal carrier vesicles (ECVs) that bud
afrom early and fuse with late endosomes or occurring
R
by a maturation process (Gruenberg and Maxfield, t
1995), has been shown to exclusively depend on dynein o
l(Aniento et al., 1993). Our findings that KIF16B modu-
lates EGFR degradation suggest that the activity of
cKIF16B balances that of dynein in regulating the trans-
aport of cargo from early to late endosomes. We have
Kobserved that transition from early to late endosomes
C
occurs by conversion of Rab5-positive into Rab7-posi- l
tive structures, a process occurring near the center of A
sthe cell (Rink, personal communication). Based on the
feffects of KIF16B, we suggest that the spatial distribu-
ction of early endosomes is critical to their ability to
3either generate ECVs or convert into late endosomes.
K
Consistently, the peripheral endosomes induced by u
KIF16B overexpression harbored early but failed to T
macquire late endosome markers. We propose that early
6endosomes can acquire cargo and recycle it to the cell
Dsurface as long as the Rab5 and PI(3)P-dependent re-
rcruitment of KIF16B keeps them near the periphery.
H
Once the activity of dynein prevails over that of KIF16B, p
the endosomes predominantly reside in the center of (
uthe cell where they become committed to switch to the
pdegradative pathway. Interestingly, when late endo-
Csomes were relocated to the cortex of the cell by dy-
Gnamitin overexpression, transport from early to late en-
dosomes was inhibited despite the close proximity of P
these organelles to each other (Valetti et al., 1999), fur- S
ther supporting the idea that intracellular localization T
pgoverns the transport activity of these organelles.
iOur results on the effect of KIF16B on EGF degra-
Tdation have important implications for signal trans-
bduction. Prior to degradation, internalized receptors
f
continue signaling by activating cytoplasmic target 1
molecules (Miaczynska et al., 2004). Since receptor a
Pdownregulation results in signal desensitization over
ttime, the trafficking role of KIF16B may also impact on
the signaling response. Remarkably, KLP98A, the Dro-
Isophila ortholog of KIF16B, has previously been linked
Tto wingless (wg) signaling (Dalby et al., 1996), opening
(
the interesting avenue of exploring the role of KIF16B m
during development. It will also be interesting to ex- w
Bplore the role of KIF16B in endocytic and transcytotic
strafficking in polarized cells. Addressing these ques-
mtions will improve our understanding of the physiologi-
Mcal role of cytoskeleton-mediated endocytic transport
b
at the cellular and multicellular levels. s
s
bExperimental Procedures
[
hAntibodies and Other Reagents
Anti-tubulin antibody (1:250) was from Sigma-Aldrich; polyclonal l
tanti-EEA1 (1:500) (Christoforidis et al., 1999) and anti-LAMP1
(1:500) from PharMingen; and anti-vps34 (Nielsen et al., 1999), d
tsheep anti-EGF receptor (Fitzgerald; 1:1000) and rhodamine-conju-ated transferrin from Molecular Probes. LY294002 and Wortman-
in were obtained from Calbiochem-Novabiochem GmbH. Cell cul-
ure reagents were from Sigma-Aldrich and Invitrogen. Other
hemicals were from Sigma, unless specified.
ell Transfection, Immunofluorescence Microscopy,
nd Time-Lapse Fluorescence Video Microscopy
eLa cell transfection was carried out using Effectene (Quiagene)/
NA complex. Oligofectamine (Invitrogen) was utilized for esiRNA
ransfection. After 24 hr (DNA) or 72 hr (RNA), cells were used for
nalysis. For videomicroscopy, cells transiently expressing GFP-
ab5 or YFP-KIF16B grown on glass coverslips were transferred
o custom-built aluminium microscope slide chambers just before
bservation. Time-lapse imaging was performed at 37°C and ana-
yzed using customized software (Gasman et al., 2003).
DNA Cloning, Sequence Analysis, Northern Blot,
nd RNA Interference
IF16B was cloned from HeLa total mRNA using ATGAGCGATGG
ATCGGTC and CTACCCCGTCCCGTGGCTG primers. The full-
ength construct was subcloned into pEYFP-N1 (CLONTECH, Palo
lto, CA) by ET recombination. For the headless KIF16B con-
tructs, carboxyl terminal sequences of human KIF16B were ampli-
ied from full-length KIF16B cDNA using PCR and subsequently
loned into pEYFP-N1 and pGEX-6P-1 to obtain KIF16B-N (aa
96–1318) and KIF16B-N2 (aa 219–1318) fusion constructs. The
IF16B-S109A construct was created by site-directed mutagenesis
sing the QuikChange Site-Directed Mutagenesis Kit (Stratagene).
he GST-KIF16B-PX construct was made by subcloning the C ter-
inus (aa 1169–1318) of KIF16B into EcoRI/SalI sites of pGEX-
P-1 following standard methods. All constructs were verified by
NA sequencing. Coils prediction of the protein sequences was
un with weighing option window size of 28 for KHC, DdKIF1A, and
sKIF16B and 21 for HsKIF1A. A human tissue Northern blot
urchased from BD Biosciences was probed for KIF16B mRNA
CTGGATTTGCGCCCAAAGAGCG, CAGAGAGAGGCGCTGGAGCGG)
sing the Dig Northern kit (Roche). KIF16B-specific esiRNA was
repared as described (Yang et al., 2002) using GTAATACGACT
ACTATAGGCAGGAGATCCTAGAG and GTAATACGACTCACTATAG
GCCCAGGGTGGAGTG primers.
olyclonal Antibody Generation, Affinity Purification,
ubcellular Fractionation, and Immunoblotting
runcated KIF16B-N (aa 396–1318) protein was expressed and
urified as GST fusion protein in E. coli, cleaved from GST, and
njected into rabbits (Elevage Scientifique des Dombes, France).
he antiserum was affinity purified using the antigen protein immo-
ilized on Sulfolink beads (Pierce). An early endosome-enriched
raction was purified from HeLa cells mock treated or treated with
00 nM Wortmannin for 30 min in 37°C as described (Nielsen et
l., 1999). The endosomes were subsequently analyzed using SDS-
AGE chromatography and immunoblotting or used for in vitro mo-
ility studies.
n Vitro Motility, Microtubules Gliding, and Liposome Assays
he in vitro motility assay was essentially carried out as described
Nielsen et al., 1999) with the following modification: KHMG (110
M KCl, 50 mM HEPES-KOH [pH 7.4], 2 mM MgCl2, 10% glycerol)
as used as assay buffer. For preparation of the antifade solution,
RB80 buffer was substituted with KHMG and the solution was
upplemented with 10% serum. The energy mix consisted of 75
M creatine phosphate, 10 mM ATP, 10 mM GTP, and 20 mM
gCl2 in BRB80. Fluorescently labeled, taxol-stabilized microtu-
ules were perfused in a microscopy chamber to bind to the cover-
lip (Nielsen et al., 1999). Next, 10 l of 10% nonspecific rabbit
erum in antifade solution was perfused in the chamber followed
y 10 l of the assay mixture (2 l fluorescently labeled endosomes
5 mg/ml], 1 l energy mix, 6 l antifade solution, and 1 l saturated
aemoglobin solution in KHMG) and incubated for 5 min at RT. At
east three movies per sample were recorded (60 frames, 2 s in-
ervals) and analyzed as described (Nielsen et al., 1999). When en-
osomal movement was analyzed using centrosome-grown micro-
ubules, all 25 recorded motility events observed were plus end
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449directed. Liposomes were prepared as described (Klopfenstein et
al., 2002) using DOPC, 2 mol% PI(3)P (Echelon Research Laborato-
ries) and 0.5 mol% TRITC-DHPE (Molecular Probes) diluted 1:100
in KHEM. To determine the directionality of the motor in the micro-
tubule-gliding assay, HIS-tagged full-length KIF16B was purified
using a baculovirus system, and 10 l of recombinant KIF16B (0.4
mg/ml) was left on a coverslip for 5 min and washed with KHMG,
and 3 l of the polarity-marked microtubules were added in BRB80
buffer containing 1 mM ATP as described (Nielsen et al., 1999). To
quantify the velocity of the motor-induced microtubule gliding,
taxol-stabilized instead of polarity-marked microtubules were
used.
Transferrin Uptake, Recycling, and EGFR Degradation
For the transferrin internalization assay, HeLa cells were trans-
fected with KIF16B-EYFP expression vector or esiRNA specific for
KIF16B or a pBluescript vector sequence (mock). At 16 hr (DNA) or
74 hr (esiRNA) posttransfection, cells were starved for 4 hr in CO2-
independent DMEM medium containing 0.2%BSA and then incu-
bated with Alexa568-labeled Tfn (Sigma-Aldrich) at 0.5 mg/ml for
the indicated times. For biochemical uptake analysis, starved cells
were allowed to internalize biotinylated Tfn (10 g/ml) for the times
indicated. Cells were placed on ice, washed, and lysed, and the
total cell extract was incubated with affinity-purified, ruthenium-
labeled, sheep-anti-human Tfn antibodies (SAPU, Scotland) and
subsequently analyzed using an ECL-Analyzer System from IGEN
Inc. (Rockville, MD). The amount of internalized Tfn was standard-
ized with respect to total protein concentration of the lysate and
expressed as percent of the amount of internalized Tfn in control
cells at t = 40 min (n = 4; mean ± SD from two independent experi-
ments). The Tfn recycling assay was carried out as described (de
Renzis et al., 2002), except that cells were rapidly washed once at
37°C with CO2-independent DMEM with 100 g/ml human holo-
Tfn (n = 4; mean ± SD from two independent experiments). EGF-
stimulated EGFR uptake and degradation were either studied by
confocal microscopy and image processing (Bache et al., 2003) or
measured biochemically. For EGFR degradation (5 × 105, 5 cm
dishes), HeLa cells were transfected for 24 hr with 400 ng of the
indicated plasmid, using Effectene (R). The cells were then incu-
bated with or without 100 ng/ml EGF for 30 min, washed, and
chased for 6 hr in normal growth medium containing 10 g/ml
cycloheximide. Cell extracts were then analyzed by SDS-PAGE and
Western blotting with anti-EGFR antibodies.
Supplemental Data
Supplemental Data include one figure and six movies and can be
found with this article online at http://www.cell.com/cgi/content/
full/121/3/437/DC1/.
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